+$32.4M
Net Activity
Institutions Holding
45
Popularity Rank
#6255
Avg Weight
0.03%
Total Value
$40.2M
45 institutions currently hold ARMP, with 21 net buyers and 7 net sellers this quarter.
Institutional Moves (Q1 2026)
Significantly Increased
Based on recent trading activity
Net Selling Institutions
7
Net Buying Institutions
21
Top 5 by Value
+$30.5M
Total Buy Value
$2.0M
Total Sell Value
21
Net Buyers
7
Net Sellers
No Form 144 planned sale filings in the last 90 days
No Schedule 13D/13G filings for this ticker
1
Filings (14d)
Armata Pharmaceuticals announced that it has reached an agreement with the FDA on an Initial Pediatric Study Plan for AP-SA02, its experimental therapy for treating complicated Staphylococcus aureus bloodstream infections in children. The agreement sets the regulatory framework for future pediatric trials required for the drug's development.
View Full Filing (SEC EDGAR)The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter